The company held a quarterly work analysis meeting.
Release time:
2020-07-22
Inventory Season Plan Year
Company Held Quarterly Work Analysis Meeting
News 4# December 22 , 23 , the company successively held work analysis meetings for pharmaceutical sector, cement sector and directly affiliated enterprises to summarize and inventory the work gains and losses in the first quarter, requirements for this year's follow-up work, especially in the second quarter. At the
analysis meeting, the person in charge of each enterprise reported the work situation in the first quarter in the form of PPT , focusing on analyzing the existing problems and proposing solutions and improvement plans. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one based on the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements.
Peak Pharmaceutical: Current production and operation and future development are both grasped
In the recent period, with a series of changes such as the deepening of medical system reform, the regulation of the pharmaceutical market, and the continuous strengthening of safety and environmental protection management, especially the implementation of new policies such as "4 7" volume procurement, the operating pressure of pharmaceutical enterprises has been increasing, the pharmaceutical market pattern and marketing model are constantly changing. The meeting held that in the current period of change in China's economy and pharmaceutical industry, Jianfeng Pharmaceutical Company should have a clear understanding, seize the opportunities brought about by the change, and make forward-looking investment and layout as soon as possible, so as to lay the foundation for future development.
meeting requires that pharmaceutical companies should fully understand the industry development trend brought about by the reform of the medical system, especially the sales department should fully understand and grasp the changes in industry policies, be market-oriented, strengthen the innovation in marketing mode, management mode and incentive mechanism, and make great efforts to do a good job in the adjustment of medical insurance catalogue and academic promotion, so as to achieve a breakthrough in marketing; earnestly grasp the technological transformation projects of Shanghai Beika and its subordinate enterprises. The product selection should be forward-looking and fully consider the future market demand and the synergy effect with the parent company's products. Pay special attention to the improvement of internal management and improve the overall operation efficiency of the enterprise; With the attitude of "zero tolerance " , we should pay special attention to safety and environmental protection management, improve the safety and environmental protection management system and process, and improve the staff's awareness and related skills. The meeting required all subordinate enterprises of pharmaceutical companies to form a close synergy advantage, do a good job in the extension of the current business chain, and achieve both current production and operation and future development.
Cement Plate: Further Strengthen Cost Control and Optimization and Adjustment of Management Organizations
In the first quarter of this year, the sales volume and benefits of Daye Peak and Yunnan Peak cement enterprises increased year on year. The meeting requested that cement enterprises should further strengthen the on-site management of mining in production and strengthen cost and quality control from the source. We should pay special attention to equipment management and production site management, ensure the operating efficiency of the production line. In sales, we should pay attention to the balance between the civil market and the public works market to ensure the stability of future market sales. At the same time, we must carefully study the connection and extension of the upstream and downstream of the industry to maximize benefits; as the country and the whole society attach importance to environmental protection, as a traditional manufacturing enterprise, we must continue to promote "Green Factory " and "The establishment of standardized demonstration factory " , and earnestly do a good job in environmental protection and safety management. With the advent of the rainy season in Yunnan, Yunnan peak also need to do a good job in the rainy season maintenance and transformation and production, the balance between the market.
Peak Health: To understand the current situation, grasp the key points, and seek breakthroughs
For several major product lines of Peak Health, the meeting required the management team to carefully analyze the current situation and market, grasp the key points to carry out work, and seek breakthroughs. In view of the actual situation of small enterprise scale and low brand influence, the meeting requires Jianfeng Health to fully grasp the balance between quality and cost, and strive to study and reduce costs on the premise of ensuring product quality; plant extracts focus on brand products with scientific and technological content and high added value, and decoction pieces should strengthen the raw material control ability of the source; in terms of marketing, efforts should be made to strengthen brand influence and improve marketing channels, improve customer stickiness through various ways to ensure sales volume.
International Trade Company: Adjust thinking, clear positioning, strengthen management and control cost
According to the operation and current business composition of international trade companies in the first quarter, the meeting asked international trade companies to further clarify the enterprise positioning of site providers of logistics enterprises and storage and distribution providers of futures trade, and adjust the organizational structure and management system around the core business, to match it with modern logistics; to extend and integrate the industrial chain in the surrounding area with the concept of value chain, to explore new logistics models; to further standardize management, to provide good services for upstream and downstream enterprises while controlling operating costs.
Cable Company: Since the new management team of
Cable Company took office, it has done a lot of work in market development and achieved certain results. The meeting required cable companies to further be market-oriented and force management and technological progress; further strengthen quality control and employee skills training, and reduce costs by reducing the failure rate and unnecessary loss; in terms of market expansion, more attention should be paid to the control of receivables, Improve the ability to obtain information, strive to increase sales in domestic, direct sales and professional markets, increase profitability, and strive for greater benefits. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31